The Board of Directors of Plus Therapeutics, Inc. has authorized a buyback plan on October 31, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.13 USD | +5.97% | +22.38% | +21.71% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.71% | 9.11M | |
+21.74% | 46.4B | |
-0.97% | 41.75B | |
+49.22% | 41.37B | |
-3.52% | 29.71B | |
+11.12% | 26.01B | |
-19.37% | 19.52B | |
+31.18% | 12.43B | |
-0.04% | 12.13B | |
+0.39% | 12.18B |
- Stock Market
- Equities
- PSTV Stock
- News Plus Therapeutics, Inc.
- Plus Therapeutics, Inc. authorizes a Buyback Plan.